Skip to main content

LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB

Publication ,  Conference
McCarthy, PL; Holstein, SA; Jung, S-H; Cooper, M; Gibson, CJ; Stadtmauer, EA; Winograd, B; Richardson, P
Published in: HAEMATOLOGICA
June 26, 2017

Duke Scholars

Published In

HAEMATOLOGICA

ISSN

0390-6078

Publication Date

June 26, 2017

Volume

102

Start / End Page

108 / 108

Location

Madrid, SPAIN

Publisher

FERRATA STORTI FOUNDATION

Conference Name

22nd Congress of the European-Hematology-Association

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McCarthy, P. L., Holstein, S. A., Jung, S.-H., Cooper, M., Gibson, C. J., Stadtmauer, E. A., … Richardson, P. (2017). LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB. In HAEMATOLOGICA (Vol. 102, pp. 108–108). Madrid, SPAIN: FERRATA STORTI FOUNDATION.
McCarthy, P. L., S. A. Holstein, S. -. H. Jung, M. Cooper, C. J. Gibson, E. A. Stadtmauer, B. Winograd, and P. Richardson. “LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB.” In HAEMATOLOGICA, 102:108–108. FERRATA STORTI FOUNDATION, 2017.
McCarthy PL, Holstein SA, Jung S-H, Cooper M, Gibson CJ, Stadtmauer EA, et al. LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 108–108.
McCarthy PL, Holstein SA, Jung S-H, Cooper M, Gibson CJ, Stadtmauer EA, Winograd B, Richardson P. LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 108–108.

Published In

HAEMATOLOGICA

ISSN

0390-6078

Publication Date

June 26, 2017

Volume

102

Start / End Page

108 / 108

Location

Madrid, SPAIN

Publisher

FERRATA STORTI FOUNDATION

Conference Name

22nd Congress of the European-Hematology-Association

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology